Use of expression of antisense mRNA for proprotein convertases 1 and 2 in prohormone processing.
Vishnuvardhan
D
D
Department of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine, Boston, Massachusetts 02111, USA.
Beinfeld
M C
MC
D016282:Aspartic Acid Endopeptidases / Q000187:drug effects / Q000235:genetics; D002766:Cholecystokinin / Q000378:metabolism*; D010450:Endopeptidases / Q000187:drug effects* / Q000235:genetics; D045706:Proprotein Convertase 2; D043484:Proprotein Convertases; D011498:Protein Precursors / Q000378:metabolism*; D011499:Protein Processing, Post-Translational; D016372:RNA, Antisense / Q000494:pharmacology*; D012333:RNA, Messenger; D013381:Subtilisins / Q000187:drug effects / Q000235:genetics
D011498:Protein Precursors; D016372:RNA, Antisense; D012333:RNA, Messenger; C060249:procholecystokinin; D002766:Cholecystokinin; D010450:Endopeptidases; D043484:Proprotein Convertases; D013381:Subtilisins; D045706:Proprotein Convertase 2; D016282:Aspartic Acid Endopeptidases